Shu Hui Chen
Corporate Officer/Principal at WUXI PHARMATECH (CAYMAN) INC. (ADR)
Shu Hui Chen active positions
| Companies | Position | Start | End |
|---|---|---|---|
| WUXI PHARMATECH (CAYMAN) INC. (ADR) | Corporate Officer/Principal | - | - |
| Chief Tech/Sci/R&D Officer | 2003-12-31 | - |
Career history of Shu Hui Chen
Former positions of Shu Hui Chen
| Companies | Position | Start | End |
|---|---|---|---|
| WUXI APPTEC CO., LTD. | Chief Tech/Sci/R&D Officer | 2003-12-31 | 2016-03-22 |
| Corporate Officer/Principal | 2003-12-31 | 2024-04-09 | |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 1997-12-31 | 2003-12-31 |
Vion Pharmaceuticals, Inc.
 Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 1994-12-31 | 1996-12-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 1994-12-31 | 1994-12-31 |
Training of Shu Hui Chen
| Yale University | Doctorate Degree |
| Fudan University | Undergraduate Degree |
Statistics
International
| United States | 5 |
| China | 4 |
Operational
| Corporate Officer/Principal | 5 |
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| WUXI APPTEC CO., LTD. | Health Technology |
| Private companies | 2 |
|---|---|
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Health Technology |
Wuxi PharmaTech (Cayman), Inc.
 Wuxi PharmaTech (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China. | Health Technology |
- Stock Market
- Insiders
- Shu Hui Chen
- Experience